21 results
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
29 Jun 21
Current report (foreign)
7:38am
to Planet Financial Performance Values-Based Governance Global Corporate Social Responsibility Legal Disclaimers Appendix Reconciliations 03 06 08 09 … , more than 60% of our research and development (R&D) pipeline is being developed with partners around the world. We have 16 Global Corporate Social Responsibility Program
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
28 May 21
Current report (foreign)
6:01am
workplaces. Takeda’s ESG commitment – including its Access to Medicines strategy and Global Corporate Social Responsibility Program – is evident through
6-K
rd5s5xpjlw49a7d2h
11 May 21
Current report (foreign)
6:08am
6-K
EX-99.1
0sg4b1d37bsk c3
17 Dec 20
Current report (foreign)
6:01am
6-K
ybxes3z099t2m f3bl
29 Jul 20
Current report (foreign)
6:07am
6-K
EX-1
uboflkp rdpvgza
27 May 20
Current report (foreign)
6:03am
6-K
esf3scal4 ji7
13 May 20
Current report (foreign)
6:03am
6-K
6b3z8a1x3e4di6znn9
14 Jan 20
Current report (foreign)
6:56am
6-K
EX-99.1
t3wsbuwn7f
10 Jan 20
Better Health, Brighter Future 2019 SUSTAINABLE VALUE REPORT Takeda Pharmaceutical Company Limited
6:36am
6-K
EX-99.1
lqc7kfrot5 jr9exe
14 Nov 19
Current report (foreign)
6:26am
424B3
3raxqgm9u fpy
14 Nov 19
Prospectus supplement
6:10am
F-4/A
gn6v7sfnlbxzh3jnmy
12 Nov 19
Registration of securities (foreign) (amended)
9:50am
F-4
rhdn1
9 Aug 19
Registration of securities (foreign)
6:27am
20-F
2weu90hygok
27 Jun 19
Annual report (foreign)
6:41am
20FR12B/A
gx0j4ydimpn
17 Dec 18
Initial registration of securities (foreign private issuers) (amended)
6:14am
20FR12B
jtmn1 xa89
6 Dec 18
Initial registration of securities (foreign private issuers)
10:39am